black box warning



Cymbalta Contract: How Eli Lilly Influences What Prescribers Learn about Lilly’s drugs Fri, 5 Aug 2005 The Wall Street Journal reports that not only do drug manufacturers control what the public is told about patented drugs, but companies, such as Eli Lilly and Pfizer dictate by contract what doctors are […]

Cymbalta Contract: How Eli Lilly Influences What Prescribers Learn about ...




GSK Sales Reps told NOT to Divulge Paxil Data / Merck Withdraws Vioxx Thu, 30 Sep 2004 The Associated Press reports: “Merck pulled Vioxx after admitting studies showed the drug raised the risk of heart attack. As recently as August, Merck “strongly” disagreed with studies showing the drug increased heart […]

GSK Sales Reps told NOT to Divulge Paxil Data / ...


AHRP Speaks Out AHRP Press Briefing 9/14/04: Antidepressants & suicide-related risks for children Open Letter to NIMH re Prozac & Concealed Suicide Attempts Open Letter to Officials at NIMH AHRP Briefing 2/2/04: Scientists present suicide evidence Conflicts of Interest policy – New York Times Phase I Drug Trials Used Foster […]

Featured News


FDA Response to Utah Court Must Be Truthful Re: Zoloft / SSRI Suicidal Risks Mon, 29 Aug 2005 Related link: FDA Amicus Curiae–Kallas–claims FDA infallibility pre-empts state safety laws (warning: large 1.6 MB file) A federal judge in Utah has asked the FDA to explain its position as it relates […]

FDA Response to Utah Court Must Be Truthful Re: Zoloft ...



Lilly Withdraws Duloxetine Application from FDA Fri, 28 Jan 2005 Eli Lilly and Boeringer Ingelheim have jointly announced that they have recinded their U.S. FDA Application for Duloxetine for Treatment of Stress Urinary Incontinence. http://newsroom.lilly.com/ReleaseDetail.cfm?ReleaseID=154081&print=yes Withdrawal of an application from FDA approval process is usually the result of the manufacturer’s […]

Lilly Withdraws Duloxetine Application from FDA


Will the Cong Oversight / Investigations Committee Ask FDA the Tough Questions? Wed, 22 Sep 2004 FDA’s complicity in concealing vital drug safety information that might have saved lives, is the subject of tomorrow’s hearing by the House subcommittee on Oversight and Investigations. Rayburn Office Bldg, room 2123 at 11:00. […]

Will the Cong Oversight / Investigations Committee Ask FDA the ...


http://www.mysanantonio.com/news/metro/stories/MYSA020305.13A.antidepressants.6d572159.htm Antidepressant warnings make experts nervous Web Posted: 02/03/2005 12:00 AM CST Marina Pisano San Antonio Express-News Even as warning labels about the risk of suicidality in children and teens taking antidepressants are going on medication labels, a new study is showing that American suicide rates have dropped significantly since […]

Antidepressant warnings make experts nervous



AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising Wed, 02 Nov 2005 FDA is holding public hearings (Nov 1, 2) Re:  Direct-to-Consumer Promotion of Medical Products at: National Transportation Safety Board Boardroom and Conference Center 429 L’Enfant Plaza, SW., Washington, DC 2 Time: 9:00 –5:00. […]

AHRP Position Statement on Mental Health Screening – FDA Hearing ...